New York, NY, May 18, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Diverticulitis Disease Market Share, Size, Trends, Industry Analysis Report, By Type (Uncomplicated, Complicated); By Treatment; By End-User; By Region; Segment Forecast, 2023-2032” in its research database.
“As per the latest research analysis, the global diverticulitis disease market size/share will be valued at roughly USD 1.56 Billion in 2022, and its revenue is projected to reach about USD 3.86 Billion by 2032. The market is forecasted to expand at a compound annual growth rate of approximately 8.91% between 2023 and 2032.”
What is Diverticulitis Diseases? How Big is Diverticulitis Disease Market?
- Overview
Diverticulitis is the infection or inflammation of small pouches called diverticula that can develop in your intestines. The condition affects the large intestine or colon, which is responsible for absorbing water from food and eliminating solid waste from the body. Diverticulitis can cause painful symptoms and serious complications in some cases. Symptoms of diverticulitis disease can include abdominal pain, distended abdomen, fever, nausea and vomiting, rectal bleeding, constipation, or, less commonly, diarrhea.
However, the exact cause of diverticulitis is not fully known, but it is thought to be related to a lack of exercise, a sedentary lifestyle, and a low-fiber diet. To prevent diverticulitis, it is recommended to maintain a healthy diet with high fiber intake, exercise regularly, and avoid smoking. Growing markets and a surge in the prevalence of gastrointestinal diseases worldwide are driving the diverticulitis market size.
Request Sample Copy of Diverticulitis Disease Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/diverticulitis-disease-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report Covers:
- 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
- 115+ Pages Research Report (Inclusion of Updated Research).
- Provide Chapter-wise guidance on Requests.
- 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures.
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Some of the Top Market Players Are:
- Pfizer
- G.D. Searle
- Teva Pharmaceutical
- Abbott Laboratories
- Braun Medical
- GSK
- Bayer HealthCare
- Roche Holding
- Johnson and Johnson
- Sucampo Pharmaceuticals
- Valeant Pharmaceuticals
- Synergy Pharmaceuticals
- Ardelyx
- Astellas Pharma
- Novartis
- Hikma Pharmaceuticals
- Baxter International
To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.polarismarketresearch.com/industry-analysis/diverticulitis-disease-market/request-for-sample
Prominent Growth Driving Factors
- Obesity and cigarette smoking population: Rising prevalence of obesity is expected to fuel the market growth. Also, the increased cigarette smoking population is boosting the diverticulitis market growth.
- Growing geriatric population: Nearly everyone over the age of 80 suffers from diverticulosis, and as people age, their likelihood of developing it increases. According to a projection by the WHO from 2022, by 2030, 1 in 6 people worldwide will be 60 years of age or older. The number of people 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million.
- Ongoing clinical trials and increased demand for diverticulitis treatment drugs: continuous ongoing clinical trials on rare disorders and a rise in demand of drugs for the treatment of diverticulitis disease are projected to drive the diverticulitis market demand.
- Health and government initiatives: Increasing health and government initiatives to enhance healthcare infrastructure such as funding for research and development of new treatments, and improved access to healthcare services, further accelerates the diverticulitis disease market growth.
Request Customized Copy of Report @ https://www.polarismarketresearch.com/industry-analysis/diverticulitis-disease-market/request-for-customization
(We customize your report according to your research need. Ask our sales team for report customization.)
Top Report Findings
- Rise in prevalence of gastrointestinal diseases, the growing geriatric population, and cases of obesity is anticipated to propel the market growth.
- The market is segmented based on type, treatment, end-user, and region.
- The market demand in North America is predicted to show significant growth during the forecast period
Recent Trends Influencing the Market
- Launch of new products: Launch of new items in the market is one of the key diverticulitis market trends expanding opportunities globally. As a result, it promotes the expansion of the expanded items. The diverticulitis illness market is expected to grow as a result of revised guidelines for treating simple acute diverticulitis.
- Antibiotics for simple acute diverticulitis: Laura Mora-López's research paper suggests that recent studies have not shown any significant benefits of using antibiotics to treat simple acute diverticulitis in hospitalized patients. The paper concludes that moderate acute diverticulitis can be safely and effectively treated without antibiotics, and this approach is comparable to the current standard of care.
Segmental Analysis
- Un-complicated is anticipated to account for the largest diverticulitis market share
By type, the un-complicated category dominated the market in 2021 owing to the ongoing advancement in the study of antibiotics for the treatment of simple diverticulitis. For instance, in 2022, Dulitha Kumarasinghe released a research report suggesting that non-antibiotic therapy could be a practical and safe approach to treating acute uncomplicated diverticulitis, as indicated by a recent publication. Another factor supporting the market growth is simple diverticulitis which is the most prevalent acute diverticular disease complication. In addition, simple acute diverticulitis can be caused due to the blockage and inflammation of a colonic diverticulum. The condition affects about 4-5% of persons with diverticulosis.
- In 2022, the medication sector will witness the largest revenue share in the diverticulitis market
Based on treatment segmentation, the medication segment is expected to dominate the market because antibiotics are utilized to combat potential infections that could arise from acute diverticulitis, which is the key cause driving market expansion. For instance, antibiotic therapy covered Gram-negative and anaerobes while focusing on the common gut bacteria. Oral ciprofloxacin and metronidazole, or amoxicillin/clavulanate, are the most typical outpatient regimens. Other antibiotics used to treat acute diverticulitis involves trimethoprim-sulfamethoxazole (Bactrim), Ciprofloxacin (Cipro), and Clavulanic acid (Augmentin).
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/diverticulitis-disease-market/inquire-before-buying
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
Diverticulitis Disease Market: Report Scope & Segmentation
| Report Attribute | Details |
| Revenue Forecast in 2032 | USD 3.86 Billion |
| Market size value in 2023 | USD 1.79 Billion |
| Expected CAGR Growth | 8.91% from 2023 - 2032 |
| Base Year | 2022 |
| Forecast Year | 2023 – 2032 |
| Top Market Players | Pfizer, G.D. Searle LLC, Teva Pharmaceutical Industries Abbott Laboratories, B. Braun Medical, GSK plc, Bayer HealthCare Pharmaceuticals, Roche Holding AG, Johnson and Johnson Services, Sucampo Pharmaceuticals, Valeant Pharmaceuticals International, Synergy Pharmaceuticals, Ardelyx, Astellas Pharma, Novartis AG, Hikma Pharmaceuticals and Baxter International. |
| Segments Covered | By Type, By Treatment, By End-Use, By Region |
| Customization Options | Customized purchase options are available to meet any research needs. Explore customized purchase options |
Geographical Overview
North America: Based on geography, the diverticulitis market in North America is expected to hold the largest market share due to such as rising obesity and smoking rates, an aging population, a rise in the need for technologically advanced therapies, and greater public awareness of local health issues during the forecast period. Overeating and inactivity are the two most common causes of obesity. Factors such as Genetics, metabolism, environment, behavior, and culture usually affect obesity. Currently, 42.4% of adults in the United States are obese. Non-Hispanic Black American women have the highest obesity rates.
Moreover, according to a 2020 research report by Alexander T. Hawkins, diverticulitis is responsible for approximately 200,000 inpatient hospital stays and 371,000 emergency department visits every year in the United States. The report further estimates the cost associated with these hospitalizations and emergency department visits to be between 2.1 and 2.6 billion dollars.
Browse the Detail Report “Diverticulitis Disease Market Share, Size, Trends, Industry Analysis Report, By Type (Uncomplicated, Complicated); By Treatment; By End-User; By Region; Segment Forecast, 2023-2032” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/diverticulitis-disease-market
For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com
Recent Developments
- In January 2022, the ACP recently released two clinical guidelines for the diagnosis and treatment of diverticulitis. According to these guidelines, the majority of patients with simple cases can be treated on an outpatient basis, and some may not even require antibiotics initially. For patients with complicated issues who have not undergone colonoscopy recently, the guidelines recommend referral for the procedure after the initial episode.
Frequently Asked Questions
- Who are the crucial companies operating the market?
- What are the major industry norms influencing the development of the industry?
- Which is the most propelling country in the industry?
- Which application or product type will obtain progressive development possibilities during the forecast period?
- What is the expected growth rate of the market during the foreseen period?
- What are the key strategies adopted by companies in the impact market?
- What are the main findings of Porter’s five forces analysis and the SWOT analysis of the major companies in the market?
Polaris Market Research has segmented the Diverticular Disease Market report based on type, treatment, end-user and region:
By Type Outlook
- Uncomplicated
- Complicated
By Treatment Outlook
- Medications
- Surgery
- Supportive care
- Penicillin Antibiotic
- Antibiotics
- Dietary Supplements
- IV fluids
By End-User Outlook
- Specialty centers
- Hospitals
- Research centers
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Browse More Research Reports:
- Air Quality Control Systems Market: https://www.polarismarketresearch.com/industry-analysis/air-quality-control-system-market
- Sustainable Pharmaceutical Packaging Market: https://www.polarismarketresearch.com/industry-analysis/sustainable-pharmaceutical-packaging-market
- North America Blower Market: https://www.polarismarketresearch.com/industry-analysis/north-america-blower-market
- Unmanned Traffic Management Market: https://www.polarismarketresearch.com/industry-analysis/unmanned-traffic-management-market
- Aircraft Electric Motors Market: https://www.polarismarketresearch.com/industry-analysis/aircraft-electric-motors-market
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com
